Rubius appoints Holles to board, Whitehead as SVP, chief quality officer

PROVIDENCE – Rubius Therapeutics Inc. has appointed Natalie Holles to its board of directors and Greg Whitehead as senior vice president and chief quality officer. Rubius, based in Cambridge, Mass., but with a facility under renovation in Smithfield, is a clinical-stage biopharmaceutical company generating red blood cells and bioengineering them into a new class of…

Want More Free?

To access 2 more articles, please log in or register for free.

Registered users get access to a limited number of free articles every month.

Register Now

Already registered? Login to access more free articles.

Purchase NowWant to share this story? Click Here to purchase a link that allows anyone to read it on any device whether or not they are a subscriber.

- Advertisement -